23.16
+0.06(+0.26%)
Currency In USD
| Previous Close | 23.1 |
| Open | 23.13 |
| Day High | 23.45 |
| Day Low | 22.75 |
| 52-Week High | 31.67 |
| 52-Week Low | 11.16 |
| Volume | 493,717 |
| Average Volume | 829,098 |
| Market Cap | 1.07B |
| PE | -10.77 |
| EPS | -2.15 |
| Moving Average 50 Days | 23.56 |
| Moving Average 200 Days | 20.38 |
| Change | 0.06 |
If you invested $1000 in Pacira BioSciences, Inc. (PCRX) 10 years ago, it would be worth $242.84 as of March 12, 2025 at a share price of $23.16. Whereas If you bought $1000 worth of Pacira BioSciences, Inc. (PCRX) shares 5 years ago, it would be worth $699.49 as of March 12, 2025 at a share price of $23.16.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Pacira BioSciences Acquires Remaining Equity Stake of GQ Bio
GlobeNewswire Inc.
Feb 27, 2025 9:00 PM GMT
-- Advances Pacira’s “5x30” path to becoming an innovative biopharmaceutical organization -- -- Adds novel, high-capacity, local-delivery platform for the development of genetic medicines with disease-modifying potential for prevalent musculoskeletal
Pacira BioSciences to Participate in Fireside Chat at Two Healthcare Conferences in March
GlobeNewswire Inc.
Feb 26, 2025 1:00 PM GMT
PARSIPPANY, N.J., Feb. 26, 2025 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to deliver innovative, non-opioid pain therapies to transform the lives of patients, today announced that it will par
Pacira to Report 2024 Financial Results on Thursday February 27, 2025
GlobeNewswire Inc.
Feb 20, 2025 1:00 PM GMT
PARSIPPANY, N.J., Feb. 20, 2025 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to deliver innovative, non-opioid pain therapies to transform the lives of patients, today announced that it will rep